Climb Bio saw some selling pressure today and moved down -4.68%
Currently CLYM isn't at a clear support/resistance line that seems tradable. But let's also consider momentum! Climb Bio has had a nice run over the last year and provided good returns to shareholders. Over the previous year, the asset has grown 498.74 percent which isn't too bad. CLYM might find some support at the 8.78 level, buyers might push the price back up from here. But it's not very clear what will happen.